Elisa Landoni
Elisa Landoni
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
1,
Mark G Woodcock
Mark G Woodcock
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
2Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC USA
1,2,
Gabriel Barragan
Gabriel Barragan
3Center for Advanced Innate Cell Therapy, Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX USA
3,
Gabriele Casirati
Gabriele Casirati
4Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Boston, USA
5Harvard Medical School, Boston, USA
4,5,
Vincenzo Cinella
Vincenzo Cinella
4Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Boston, USA
5Harvard Medical School, Boston, USA
4,5,
Simone Stucchi
Simone Stucchi
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
1,
Leah M Flick
Leah M Flick
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
1,
Tracy A Withers
Tracy A Withers
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
1,
Hanna Hudson
Hanna Hudson
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
1,
Giulia Casorati
Giulia Casorati
6Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
6,
Paolo Dellabona
Paolo Dellabona
6Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
6,
Pietro Genovese
Pietro Genovese
4Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Boston, USA
5Harvard Medical School, Boston, USA
4,5,
Barbara Savoldo
Barbara Savoldo
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
7Department of Pediatrics, University of North Carolina, Chapel Hill, NC USA
1,7,
Leonid S Metelitsa
Leonid S Metelitsa
3Center for Advanced Innate Cell Therapy, Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX USA
3,
Gianpietro Dotti
Gianpietro Dotti
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
8Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC USA
1,8,✉
1Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA
2Division of Oncology, Department of Medicine, University of North Carolina, Chapel Hill, NC USA
3Center for Advanced Innate Cell Therapy, Texas Children’s Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX USA
4Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Boston, USA
5Harvard Medical School, Boston, USA
6Experimental Immunology Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
7Department of Pediatrics, University of North Carolina, Chapel Hill, NC USA
8Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC USA
Subject terms: Cancer immunotherapy, Interleukins, Tumour immunology
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
